The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China

Despite progress in global health, the general disease burden still disproportionately falls on low- and middle-income countries. The health needs of these countries ’ populations are unmet because there is a s...
Source: Globalization and Health - Category: International Medicine & Public Health Authors: Tags: Commentary Source Type: research